Seizert Capital Partners LLC decreased its position in Amdocs Limited (NASDAQ:DOX – Free Report) by 5.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 508,191 shares of the technology company’s stock after selling 29,743 shares during the quarter. Amdocs accounts for 2.0% of Seizert Capital Partners LLC’s portfolio, making the stock its 19th biggest holding. Seizert Capital Partners LLC’s holdings in Amdocs were worth $46,367,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Quarry LP increased its position in Amdocs by 42.2% in the first quarter. Quarry LP now owns 391 shares of the technology company’s stock worth $36,000 after purchasing an additional 116 shares during the last quarter. Rossby Financial LCC bought a new stake in shares of Amdocs in the 2nd quarter worth about $41,000. SVB Wealth LLC purchased a new stake in shares of Amdocs during the 1st quarter valued at about $43,000. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Amdocs by 537.8% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock valued at $43,000 after acquiring an additional 398 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its position in Amdocs by 213.9% in the first quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company’s stock worth $64,000 after acquiring an additional 477 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. Stifel Nicolaus decreased their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Thursday, October 30th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Bank of America cut their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Finally, Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $97.00.
Amdocs Stock Up 1.3%
Shares of Amdocs stock opened at $76.02 on Wednesday. The business has a fifty day simple moving average of $82.62 and a 200 day simple moving average of $87.07. The stock has a market cap of $8.58 billion, a PE ratio of 15.42, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 12 month low of $74.32 and a 12 month high of $95.41.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its earnings results on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.82 by $0.01. The firm had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The company’s revenue was down 9.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.70 earnings per share. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. Research analysts predict that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be paid a $0.527 dividend. This represents a $2.11 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Wednesday, December 31st. Amdocs’s dividend payout ratio is presently 41.58%.
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- Top Stocks Investing in 5G Technology
- Healthcare Rotation Underway: 3 Stocks Leading the Charge
- What is Insider Trading? What You Can Learn from Insider Trading
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- Why Are These Companies Considered Blue Chips?
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
